Kura Oncology, Inc. (KURA)
8.615
+0.28
(+3.30%)
USD |
NASDAQ |
Apr 02, 16:00
8.615
0.00 (0.00%)
After-Hours: 18:57
Kura Oncology Research and Development Expense (TTM) : 251.07M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Lexicon Pharmaceuticals, Inc. | 60.50M |
| Viemed Healthcare, Inc. | 3.017M |
| Liquidia Corp. | 38.35M |
| Agenus, Inc. | 79.34M |
| Curis, Inc. | 28.25M |